Observational studyBMC public health2023
Sarcopenia parameters in active older adults - an eight-year longitudinal study.
Observational study in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04899531 (Longitudinal PANGeA Mass Measurement - Physical Activity and Nutrition for Quality Ageing), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Longitudinal PANGeA Mass Measurement - Physical Activity and Nutrition for Quality Ageing
Who cites it
15 citing papers in PubMed, 19 citations in OpenAlex.
- [Effect of the Otago Exercise Program on Activities of Daily Living in Older Adults With Sarcopenia].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025Trial
- Sex differences in insulin resistance and basal insulin secretion among elderly men and women without a history of diabetes: a comparative study between obese and non-obese groups.Diabetology international · 2026Article
- Inter-Session Reliability of an Isometric Muscle Strength Protocol in Older Adults.Journal of functional morphology and kinesiology · 2026Article
- Tensiomyography-derived contractile parameters in sarcopenic and non-sarcopenic older adults.Frontiers in aging · 2026Article
- Health-related effects of walking football in older adults: A real-world longitudinal study across a season comparing two age groups.PloS one · 2026Article
- Combined Protein, Probiotics, and Exercise Therapy for Sarcopenia: A Comprehensive Review.Cells · 2025Review
- Clinical significance of serum irisin, 25(OH)D3 and albumin in older adults with chronic disease and sarcopenia.Aging clinical and experimental research · 2025Article
- Health-related quality of life in older Koreans: a HINT-8-based cross-sectional analysis of obesity, sarcopenia, and sarcopenic obesity using the 2023 Korea National Health and Nutrition Examination Survey.Korean journal of family medicine · 2025Article
- Determinants of dementia risk among older adults with probable sarcopenia and sarcopenia.BMC public health · 2025Article
- Physical exercise for primary sarcopenia: an expert opinion.Frontiers in rehabilitation sciences · 2025Review
- Physical Functioning, Physical Activity, and Variability in Gait Performance during the Six-Minute Walk Test.Sensors (Basel, Switzerland) · 2024Article
- Response to the Commentary on: "Pectoralis muscle area measured at T4 level is closely associated with adverse COVID-19 outcomes in hospitalized patients".Journal of musculoskeletal & neuronal interactions · 2024Article
- Correlation between Physical Performance and Tensiomyographic and Myotonometric Parameters in Older Adults.Healthcare (Basel, Switzerland) · 2023Article
- Relationship between muscle mass and muscle strength with physical performance in older adults: A systematic review.SAGE open medicine · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 9 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroudSarcopenia is a common skeletal muscle syndrome that is common in older adults but can be mitigated by adequate and regular physical activity. The development and severity of sarcopenia is favored by several factors, the most influential of which are a sedentary lifestyle and physical inactivity. The aim of this observational longitudinal cohort study was to evaluate changes in sarcopenia parameters, based on the EWGSOP2 definition in a population of active older adults after eight years. It was hypothesized that selected active older adults would perform better on sarcopenia tests than the average population.
methodsThe 52 active older adults (22 men and 30 women, mean age: 68.4 ± 5.6 years at the time of their first evaluation) participated in the study at two time points eight-years apart. Three sarcopenia parameters were assessed at both time points: Muscle strength (handgrip test), skeletal muscle mass index, and physical performance (gait speed), these parameters were used to diagnose sarcop0enia according to the EWGSOP2 definition. Additional motor tests were also performed at follow-up measurements to assess participants' overall fitness. Participants self-reported physical activity and sedentary behavior using General Physical Activity Questionnaire at baseline and at follow-up measurements.
resultsIn the first measurements we did not detect signs of sarcopenia in any individual, but after 8 years, we detected signs of sarcopenia in 7 participants. After eight years, we detected decline in ; muscle strength (-10.2%; p < .001), muscle mass index (-5.4%; p < .001), and physical performance measured with gait speed (-28.6%; p < .001). Similarly, self-reported physical activity and sedentary behavior declined, too (-25.0%; p = .030 and - 48.5%; p < .001, respectively).
conclusionsDespite expected lower scores on tests of sarcopenia parameters due to age-related decline, participants performed better on motor tests than reported in similar studies. Nevertheless, the prevalence of sarcopenia was consistent with most of the published literature.
trial registrationThe clinical trial protocol was registered on ClinicalTrials.gov, identifier: NCT04899531.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.